Furthermore, enzymatic assays indicate that CA IX exhibits higher catalytic activity in low pH environments, which is consistent with the hypoxic and acidic TME resulting from metabolic reprogramming in tumor cells [23]. The gene discussed is CA9; the disease is neoplasm.